{
  "retracted": false,
  "timestamp": 1460073600000,
  "updates": [
    {
      "timestamp": 1585087602068,
      "identifier": {
        "doi": "10.1007/s11523-016-0433-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s11523-015-0369-6"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy"
}
